COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Exosens secures €140 million in EIB financing to foster innovation in Europe’s defense and security industry
Exosens secures €140 million EIB financing to foster innovation in Europe's defense and security industry, supporting technology development and industrial footprint in line with EIB strategic priorities -
COMMUNIQUÉ DE PRESSE
Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line–Derived MVA Vaccine Candidate (TG MVA(TM)) at WCID 2026
Transgene to present positive preclinical data on TG-MVATM vaccine candidate against Mpox at WCID 2026. The cell-line based vaccine offers robust protection with scalable manufacturing -
COMMUNIQUÉ DE PRESSE
Transgene présente des données précliniques de son vaccin innovant contre le mpox produit sur lignée cellulaire, TG-MVA
Transgene présente des données précliniques prometteuses de son vaccin innovant contre le mpox, basé sur MVA et produit sur lignée cellulaire, au World Congress on Infectious Diseases. Potentiel d'approvisionnement global en vaccins -
-
-
COMMUNIQUÉ DE PRESSE
4th Chain Expo "Launchpad" Kicks Off with Over 30 Launch Events to Be Held
The 4th Chain Expo 'Launchpad' of the China International Supply Chain Promotion Expo kicks off with over 30 launch events showcasing new products, technologies, and innovation in various supply chain sectors -
-
-
COMMUNIQUÉ DE PRESSE
DocMorris announces accelerated implementation of its “AI-First” strategy; positive cost savings of at least CHF 15 million per year
DocMorris accelerates 'AI-First' strategy, targeting CHF 15m annual cost savings. Automation & efficiency gains lead to FTE reductions & enhanced customer-centric focus
